Clinical Study

Adherence and Persistence with Once-Daily Teriparatide in Japan: A Retrospective, Prescription Database, Cohort Study

Figure 3

Survival curve for persistence with once-daily teriparatide during the 12-month study period by time frame of treatment. Early initiators started treatment during months 1–4 of once-daily teriparatide availability, whereas later initiators started treatment during months 5–8 of once-daily teriparatide availability. Persistence was defined as the time from the start of treatment to the discontinuation of treatment. Discontinuation was defined as a 60-day gap in once-daily teriparatide supply. + indicates censored.
654218.fig.003